Choi, Jun-Young
Park, Hyun-Jin
Park, Sang-Min
Kang, Chang-Nam
Song, Kwang-Sup
Funding for this research was provided by:
CGBio (06-2020-0389)
Article History
Received: 30 May 2022
Accepted: 14 August 2022
First Online: 31 August 2022
Declarations
:
: The design and protocol of this multicenter, assessor-blinded, open-label, prospective, randomized controlled equivalence trial were approved by the Seoul National University Bundang Hospital institutional review board (IRB No: B-2008-630-003) of participating hospitals in Korea. Written informed consent will be obtained from all participants.
: Not applicable.
: S-MP, H-JP, K-SS, and C-NK report receiving research grant from CGBio incorporation for conducting this clinical trial.
: Some hospitals are conducting trials by recruiting participants who meet the inclusion criteria, obtaining explanations and consent.
: There are no publications containing the results of this study.